0001474506-23-000019.txt : 20230110 0001474506-23-000019.hdr.sgml : 20230110 20230110162925 ACCESSION NUMBER: 0001474506-23-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230109 FILED AS OF DATE: 20230110 DATE AS OF CHANGE: 20230110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SKIBSTED RUSSELL CENTRAL INDEX KEY: 0001308105 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34703 FILM NUMBER: 23521447 MAIL ADDRESS: STREET 1: 15 TRANQUILITY PLACE CITY: LADERA RANCH STATE: CA ZIP: 92694 FORMER NAME: FORMER CONFORMED NAME: Skibsted Russell DATE OF NAME CHANGE: 20041108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200028718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-990-5740 MAIL ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2023-01-09 0 0001267602 ALIMERA SCIENCES INC ALIM 0001308105 SKIBSTED RUSSELL 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 0 1 0 0 Chief Financial Officer & SVP Common Stock 2023-01-09 4 A 0 17500 0 A 17500 D Employee Stock Option (Right to Buy) 2.82 2023-01-09 4 A 0 52500 0 A 2033-01-08 Common Stock 52500 52500 D The Reporting Person was awarded 17,500 shares of restricted common stock in connection with his service as an executive officer of the Issuer, which shares vest in four equal annual installments beginning January 9, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the Grant Date through the applicable anniversary thereof. Becomes exercisable: (a) with respect to 13,125 options, when the Reporting Person completes 12 months of continuous service with the Issuer, and (b) with respect to the remaining 39,375 options, in equal monthly installments over 36 months beginning one month after the vesting commencement date of January 9, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the Grant Date through the applicable vesting date. /s/ Russell Skibsted 2023-01-10